Het Groene Hart Ziekenhuis is een ziekenhuis in Gouda. Bij het ziekenhuis behoren tevens de locatie Zuidplas in Nieuwerkerk aan den IJssel en de locatie Schoonhoven. Het ziekenhuis telt ruim 2000 medewerkers en heeft 620 bedden.

During the past decade, Groene Hart Ziekenhuis conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 7 clinical trials were completed, i.e. on average, 15.9% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 4 clinical trials were completed. i.e. 21.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Groene Hart Ziekenhuis" #1 sponsor was "Maastricht University Medical Center" with 6 trials, followed by "Radboud University Medical Center" with 5 trials sponsored, "The Netherlands Cancer Institute" with 5 trials sponsored, "Erasmus Medical Center" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Groene Hart Ziekenhuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 11 trials as a collaborator, "Borstkanker Onderzoek Groep" with 7 trials as a collaborator, "Dutch Cancer Society" with 4 trials as a collaborator, "Groene Hart Ziekenhuis" with 4 trials as a collaborator and "Medical Center Haaglanden" with 4 trials as a collaborator. Other collaborators include 153 different institutions and companies that were collaborators in the rest 134 trials.

According to Clinical.Site data, the most researched conditions in "Groene Hart Ziekenhuis" are "Breast Cancer" (4 trials), "Breast Neoplasms" (3 trials), "Cardiovascular Disease" (3 trials), "Deep Venous Thrombosis" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Groene Hart Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Groene Hart Ziekenhuis" are "Drug" (34 trials), "Other" (14 trials), "Procedure" (14 trials), "Device" (11 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "LMWH" (2 trials), "Ocrelizumab" (2 trials), "Rituximab" (2 trials) and "Sacral Neuromodulation" (2 trials). Other intervention names were less common.

The vast majority of trials in "Groene Hart Ziekenhuis" are 59 trials for "All" genders, 11 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Groene Hart Ziekenhuis". undefined are not yet recruiting, 12 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Groene Hart Ziekenhuis, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Groene Hart Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 27 trials that are defined as “Not Applicable".